The “12th Five-Year Plan†pharmaceutical distribution industry planning that is seeking opinions from multiple parties will be locked in advocating the diversified development of the industry, promoting the rational assessment of circulation companies and strengthening commercialization norms.
Recently, a reporter from the "Medicine Economics News" learned from the person familiar with the policy plan drawn up by the Ministry of Commerce that the Ministry of Commerce entrusted the China National Association for Pharmaceutical Enterprise Management to study and formulate the "National Pharmaceutical Distribution Industry Development Plan (2011-2015)" (under The framework for the "Twelfth Five-Year Plan" circulation industry planning) has taken initial shape. At present, specific details are being heard in the industry.
According to reports, the "Twelfth Five-Year Plan" circulation industry plan mainly includes the promotion of diversified development of the circulation industry, the encouragement of multiple formats, the support of third-party logistics, the rational establishment of grading evaluation standards for commercial enterprises, the establishment of a unified national drug code within a time limit, and the improvement of the pharmaceutical cold chain. Build and support 9 basic contents such as e-commerce.
At the same time, the reporter was also informed that in order to further solicit opinions from pharmaceutical companies, the China Pharmaceutical Enterprise Management Association will soon hold a seminar on development plans for pharmaceutical distribution industries and grading evaluation standards for pharmaceutical distribution companies involving related companies and state departments. The detailed contents of the “Twelfth Five-Year†circulation industry planning outline will be further discussed at the meeting.
Advocates for the co-existence of large and medium-sized enterprises The reporter learned that according to the national new medical reform plan, it is necessary to “improve the pharmaceutical industry development policy and industry development plan, vigorously regulate and rectify the circulation order, promote the optimization and upgrading of industrial structure, develop modern logistics and chain operations, and promote the circulation of medicines. The requirements for the integration of enterprises, taking into account the various mergers and acquisitions integration actions of the central and local state-owned enterprises in the pharmaceutical industry, and the possible development trends in the future, the “Twelfth Five-Year Plan†distribution industry planning in the above nine basic content, first of all What is proposed is to promote the direction of diversified development of the pharmaceutical distribution industry in the future, support the complementarity of multiple industries, and the coexistence of large and small enterprises, and will also support third-party logistics.
Yu Mingde, president of the China Pharmaceutical Industry Association, said: “The obvious trend that can be seen in the current series of mergers and acquisitions by major pharmaceutical companies is that state-owned enterprises are using their own solid financial strength to expand their sites. This method is a joy or a worry. It has yet to be verified, but it is not too normal."
Yu Mingde believes that as a special consumer product, the drug industry itself is fully competitive, but in the pharmaceutical circulation reform, state-owned enterprises rely on their own financial advantages to carry out large-scale nationalization operations, and even form a wholly state-owned enterprise, which is not conducive to the pharmaceutical circulation industry. The continuous development.
“For the industry that is related to the lifeline of the national economy and the basic industry of the national economy, the state needs state-owned investment. However, for the pharmaceutical distribution industry in China, it is more necessary to diversify property rights and encourage private and foreign companies to participate in the competition. We need to think about it. If it is a unified industry formed by these large groups, there is no need for circulation reform,†Yu Mingde said.
According to the formulation of the "Twelfth Five-Year Plan" circulation industry plan, the pharmaceutical circulation industry will continue to support the diversified development of the industry. In the future, it will also insist on the complementarity of multiple industries and the coexistence of large and small enterprises. That is, while advocating high-efficiency, large-scale, intensive, modern logistics and information technology development and application, it does not rule out the existence of long-term agent-type and small-medium medicine circulation enterprises; while advocating the development of pharmaceutical chain pharmacies, it does not rule out the long-term monopoly drugstores. exist.
In addition, the “Twelfth Five-Year†circulation industry plan will also reflect the role of third-party logistics in achieving the optimization and sharing of national resources. Yu Mingde said that the third party logistics is the high efficiency brought about by resource sharing, which is very beneficial to the full use of various resources of the country, and whether or not it is beneficial to the enterprise depends on the characteristics of the enterprise itself.
"This is a market-oriented choice. The Ministry of Railways or the Ministry of Posts, etc. can do anything. It is reasonable to just follow the regulations and get qualifications," Yu Mingde said.
Emphasizing evaluation of objectivity The reporter also learned that one of the basic contents of the “Twelfth Five-Year Plan†circulation industry planning also involves the grading evaluation standards for pharmaceutical distribution enterprises that are also drafted by the China Pharmaceutical Industry Management Association. It is reported that the "12th Five-Year Plan" circulation industry planning evaluation of enterprises is - circulation of enterprise evaluation will focus on ability, efficiency, light assets, allowing companies to use all.
This idea is mainly directed at the GSP revised opinions put forward by modern logistics companies must have some hard equipment and other content.
"These equipments are needed for the circulation of medicines, but not every company must have them, and they need companies to choose according to their own actual conditions rather than the conditions that must be met in the enterprise review, or after reaching certain hardware requirements. It is believed that the company is a company that meets the standards of modern logistics.†The aforementioned person familiar with the Ministry of Commerce stated.
Yu Mingde also believes that allowing enterprises to use all of them is the biggest saving of resources. He also revealed that the relevant ministries and commissions may have noticed this problem and have already been reflected in the latest version of the GSP's solicitation of opinions, and may eventually allow companies to use all of them.
Suggestions for Promoting Standardization In addition to grasping the development direction of the industry and formulating relevant standards, the “12th Five-Year Plan†circulation industry plan also put forward some opinions and suggestions on the promotion of the standardization of the pharmaceutical circulation industry for the pharmaceutical circulation regulatory department. These include: It is recommended that the country will no longer build its own pharmacy in order to fully utilize the resources of the 370,000 retail drugstores in the building of new grass-roots medical institutions in the future, and at the same time promote the more rational use and saving of national investment in health care reform; Sharing of medical institutions' stocks, pushing drugs to zero inventory in hospital drug reserves, to improve the efficiency of hospital operations, solve the problem of hospitals occupying large amounts of drugs, but disagree with the "one-on-one" non-competition mechanism model designated by the government. .
In addition, it is also recommended that the country rapidly improve the pharmaceutical cold chain construction and incorporate it into the new GSP. At the same time, it is recommended that the national regulatory authorities issue a unified national drug code within a time limit to solve the bottleneck that has always constrained the development of China's pharmaceutical logistics and the existing logistics company's “one code and one code†situation, in order to achieve mutual support with modern logistics and cold chain technologies. Save resources in all aspects.
Finally, the "Twelfth Five-Year Plan" circulation industry plan also suggests that the state increase its efforts to promote the development of e-commerce in pharmaceuticals. It is recommended that in accordance with international practice, tax exemption policies for e-commerce drugs be granted.
Recently, a reporter from the "Medicine Economics News" learned from the person familiar with the policy plan drawn up by the Ministry of Commerce that the Ministry of Commerce entrusted the China National Association for Pharmaceutical Enterprise Management to study and formulate the "National Pharmaceutical Distribution Industry Development Plan (2011-2015)" (under The framework for the "Twelfth Five-Year Plan" circulation industry planning) has taken initial shape. At present, specific details are being heard in the industry.
According to reports, the "Twelfth Five-Year Plan" circulation industry plan mainly includes the promotion of diversified development of the circulation industry, the encouragement of multiple formats, the support of third-party logistics, the rational establishment of grading evaluation standards for commercial enterprises, the establishment of a unified national drug code within a time limit, and the improvement of the pharmaceutical cold chain. Build and support 9 basic contents such as e-commerce.
At the same time, the reporter was also informed that in order to further solicit opinions from pharmaceutical companies, the China Pharmaceutical Enterprise Management Association will soon hold a seminar on development plans for pharmaceutical distribution industries and grading evaluation standards for pharmaceutical distribution companies involving related companies and state departments. The detailed contents of the “Twelfth Five-Year†circulation industry planning outline will be further discussed at the meeting.
Advocates for the co-existence of large and medium-sized enterprises The reporter learned that according to the national new medical reform plan, it is necessary to “improve the pharmaceutical industry development policy and industry development plan, vigorously regulate and rectify the circulation order, promote the optimization and upgrading of industrial structure, develop modern logistics and chain operations, and promote the circulation of medicines. The requirements for the integration of enterprises, taking into account the various mergers and acquisitions integration actions of the central and local state-owned enterprises in the pharmaceutical industry, and the possible development trends in the future, the “Twelfth Five-Year Plan†distribution industry planning in the above nine basic content, first of all What is proposed is to promote the direction of diversified development of the pharmaceutical distribution industry in the future, support the complementarity of multiple industries, and the coexistence of large and small enterprises, and will also support third-party logistics.
Yu Mingde, president of the China Pharmaceutical Industry Association, said: “The obvious trend that can be seen in the current series of mergers and acquisitions by major pharmaceutical companies is that state-owned enterprises are using their own solid financial strength to expand their sites. This method is a joy or a worry. It has yet to be verified, but it is not too normal."
Yu Mingde believes that as a special consumer product, the drug industry itself is fully competitive, but in the pharmaceutical circulation reform, state-owned enterprises rely on their own financial advantages to carry out large-scale nationalization operations, and even form a wholly state-owned enterprise, which is not conducive to the pharmaceutical circulation industry. The continuous development.
“For the industry that is related to the lifeline of the national economy and the basic industry of the national economy, the state needs state-owned investment. However, for the pharmaceutical distribution industry in China, it is more necessary to diversify property rights and encourage private and foreign companies to participate in the competition. We need to think about it. If it is a unified industry formed by these large groups, there is no need for circulation reform,†Yu Mingde said.
According to the formulation of the "Twelfth Five-Year Plan" circulation industry plan, the pharmaceutical circulation industry will continue to support the diversified development of the industry. In the future, it will also insist on the complementarity of multiple industries and the coexistence of large and small enterprises. That is, while advocating high-efficiency, large-scale, intensive, modern logistics and information technology development and application, it does not rule out the existence of long-term agent-type and small-medium medicine circulation enterprises; while advocating the development of pharmaceutical chain pharmacies, it does not rule out the long-term monopoly drugstores. exist.
In addition, the “Twelfth Five-Year†circulation industry plan will also reflect the role of third-party logistics in achieving the optimization and sharing of national resources. Yu Mingde said that the third party logistics is the high efficiency brought about by resource sharing, which is very beneficial to the full use of various resources of the country, and whether or not it is beneficial to the enterprise depends on the characteristics of the enterprise itself.
"This is a market-oriented choice. The Ministry of Railways or the Ministry of Posts, etc. can do anything. It is reasonable to just follow the regulations and get qualifications," Yu Mingde said.
Emphasizing evaluation of objectivity The reporter also learned that one of the basic contents of the “Twelfth Five-Year Plan†circulation industry planning also involves the grading evaluation standards for pharmaceutical distribution enterprises that are also drafted by the China Pharmaceutical Industry Management Association. It is reported that the "12th Five-Year Plan" circulation industry planning evaluation of enterprises is - circulation of enterprise evaluation will focus on ability, efficiency, light assets, allowing companies to use all.
This idea is mainly directed at the GSP revised opinions put forward by modern logistics companies must have some hard equipment and other content.
"These equipments are needed for the circulation of medicines, but not every company must have them, and they need companies to choose according to their own actual conditions rather than the conditions that must be met in the enterprise review, or after reaching certain hardware requirements. It is believed that the company is a company that meets the standards of modern logistics.†The aforementioned person familiar with the Ministry of Commerce stated.
Yu Mingde also believes that allowing enterprises to use all of them is the biggest saving of resources. He also revealed that the relevant ministries and commissions may have noticed this problem and have already been reflected in the latest version of the GSP's solicitation of opinions, and may eventually allow companies to use all of them.
Suggestions for Promoting Standardization In addition to grasping the development direction of the industry and formulating relevant standards, the “12th Five-Year Plan†circulation industry plan also put forward some opinions and suggestions on the promotion of the standardization of the pharmaceutical circulation industry for the pharmaceutical circulation regulatory department. These include: It is recommended that the country will no longer build its own pharmacy in order to fully utilize the resources of the 370,000 retail drugstores in the building of new grass-roots medical institutions in the future, and at the same time promote the more rational use and saving of national investment in health care reform; Sharing of medical institutions' stocks, pushing drugs to zero inventory in hospital drug reserves, to improve the efficiency of hospital operations, solve the problem of hospitals occupying large amounts of drugs, but disagree with the "one-on-one" non-competition mechanism model designated by the government. .
In addition, it is also recommended that the country rapidly improve the pharmaceutical cold chain construction and incorporate it into the new GSP. At the same time, it is recommended that the national regulatory authorities issue a unified national drug code within a time limit to solve the bottleneck that has always constrained the development of China's pharmaceutical logistics and the existing logistics company's “one code and one code†situation, in order to achieve mutual support with modern logistics and cold chain technologies. Save resources in all aspects.
Finally, the "Twelfth Five-Year Plan" circulation industry plan also suggests that the state increase its efforts to promote the development of e-commerce in pharmaceuticals. It is recommended that in accordance with international practice, tax exemption policies for e-commerce drugs be granted.
Hydrolyzed Sponge White Powder
Sponge
Chengdu Sino Tech company , https://www.cnherbfun.cn